BG104761A - Benzofurylpyrone derivatives - Google Patents
Benzofurylpyrone derivativesInfo
- Publication number
- BG104761A BG104761A BG104761A BG10476100A BG104761A BG 104761 A BG104761 A BG 104761A BG 104761 A BG104761 A BG 104761A BG 10476100 A BG10476100 A BG 10476100A BG 104761 A BG104761 A BG 104761A
- Authority
- BG
- Bulgaria
- Prior art keywords
- represents hydrogen
- benzofurylpyrone
- derivatives
- remedies
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Farming Of Fish And Shellfish (AREA)
- Furan Compounds (AREA)
- Luminescent Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6135698 | 1998-03-12 | ||
| PCT/JP1999/001225 WO1999046262A1 (fr) | 1998-03-12 | 1999-03-12 | Derives de benzofurylpyrone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG104761A true BG104761A (en) | 2001-08-31 |
Family
ID=13168805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG104761A BG104761A (en) | 1998-03-12 | 2000-09-12 | Benzofurylpyrone derivatives |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6589984B1 (fr) |
| EP (1) | EP1063235B1 (fr) |
| JP (1) | JP3922884B2 (fr) |
| KR (1) | KR100595332B1 (fr) |
| CN (1) | CN1170827C (fr) |
| AT (1) | ATE266659T1 (fr) |
| AU (1) | AU756965B2 (fr) |
| BG (1) | BG104761A (fr) |
| BR (1) | BR9908706A (fr) |
| CA (1) | CA2323456A1 (fr) |
| DE (1) | DE69917237T2 (fr) |
| EE (1) | EE200000504A (fr) |
| HR (1) | HRP20000600A2 (fr) |
| HU (1) | HUP0101381A3 (fr) |
| ID (1) | ID27511A (fr) |
| IL (1) | IL138279A0 (fr) |
| IS (1) | IS5617A (fr) |
| NO (1) | NO20004517L (fr) |
| NZ (1) | NZ506802A (fr) |
| PL (1) | PL343419A1 (fr) |
| RU (1) | RU2199536C2 (fr) |
| SK (1) | SK13412000A3 (fr) |
| TR (1) | TR200002642T2 (fr) |
| UA (1) | UA58587C2 (fr) |
| WO (1) | WO1999046262A1 (fr) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU756965B2 (en) * | 1998-03-12 | 2003-01-30 | Microbial Chemistry Research Foundation | Benzofurylpyrone derivatives |
| AU2001288432A1 (en) | 2000-09-01 | 2002-03-22 | Icos Corporation | Materials and methods to potentiate cancer treatment |
| DE10115408A1 (de) * | 2001-03-29 | 2002-10-02 | Bayer Ag | Benzofuran-Derivate |
| PT1485377E (pt) * | 2002-02-25 | 2010-03-12 | Kudos Pharm Ltd | Piranonas úteis como inibidores da atm |
| DE10314610A1 (de) | 2003-04-01 | 2004-11-04 | Aventis Pharma Deutschland Gmbh | Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung |
| BRPI0715160A2 (pt) | 2006-08-08 | 2013-06-11 | Sanofi Aventis | imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso |
| EP2025674A1 (fr) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament |
| DE102007063671A1 (de) * | 2007-11-13 | 2009-06-25 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| FR2929276B1 (fr) * | 2008-04-01 | 2010-04-23 | Servier Lab | Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2010003624A2 (fr) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Composés hétérocycliques, leurs procédés de préparation, médicaments comprenant lesdits composés et leur utilisation |
| WO2010068601A1 (fr) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant |
| EP2470552B1 (fr) | 2009-08-26 | 2013-11-13 | Sanofi | Nouveaux hydrates de fluoroglycoside hétéroaromatiques cristallins, produits pharmaceutiques comprenant ces composés et leur utilisation |
| EP2582709B1 (fr) | 2010-06-18 | 2018-01-24 | Sanofi | Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases |
| EP2683698B1 (fr) | 2011-03-08 | 2017-10-04 | Sanofi | Dérivés benzyl-oxathiazine substitués avec adamantane ou noradamantane, médicaments contenant ces composés et leur utilisation |
| WO2012120052A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| EP2683701B1 (fr) | 2011-03-08 | 2014-12-24 | Sanofi | Dérivés d'oxathiazine substitués par des groupes de benzyle-méthyles ou d'hétéro-méthyles, leur procédé de fabrication, leur utilisation comme médicament ainsi que médicaments en étant pourvu et leur utilisation |
| EP2683702B1 (fr) | 2011-03-08 | 2014-12-24 | Sanofi | Nouveaux dérivés de phényle-oxathiazine substitués, leur procédé de fabrication, médicament contenant ces liaisons et son utilisation |
| WO2012120055A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
| WO2012120057A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, agent pharmaceutique contenant ces composés et leur utilisation |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2567959B1 (fr) | 2011-09-12 | 2014-04-16 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
| DE102014214016A1 (de) | 2014-07-18 | 2015-11-05 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Leichtbaustruktur und Verfahren zur Herstellung einer Leichtbaustruktur |
| US11433047B2 (en) * | 2015-10-09 | 2022-09-06 | Neurotheryx Canada Ltd. | Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4668803A (en) * | 1984-05-10 | 1987-05-26 | Atlantic Richfield Company | Benzafuran derivatives |
| DE4308451A1 (de) | 1992-09-10 | 1994-04-14 | Bayer Ag | 3-Aryl-pyron-Derivate |
| ZA938019B (en) | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| US6005103A (en) | 1993-11-19 | 1999-12-21 | Warner-Lambert Company | Pyrone derivatives as protease inhibitors and antiviral agents |
| AU756965B2 (en) * | 1998-03-12 | 2003-01-30 | Microbial Chemistry Research Foundation | Benzofurylpyrone derivatives |
-
1999
- 1999-03-12 AU AU32773/99A patent/AU756965B2/en not_active Ceased
- 1999-03-12 WO PCT/JP1999/001225 patent/WO1999046262A1/fr not_active Application Discontinuation
- 1999-03-12 RU RU2000125690/04A patent/RU2199536C2/ru not_active IP Right Cessation
- 1999-03-12 IL IL13827999A patent/IL138279A0/xx unknown
- 1999-03-12 SK SK1341-2000A patent/SK13412000A3/sk unknown
- 1999-03-12 CN CNB99805917XA patent/CN1170827C/zh not_active Expired - Fee Related
- 1999-03-12 AT AT99939191T patent/ATE266659T1/de not_active IP Right Cessation
- 1999-03-12 DE DE69917237T patent/DE69917237T2/de not_active Expired - Fee Related
- 1999-03-12 EP EP99939191A patent/EP1063235B1/fr not_active Expired - Lifetime
- 1999-03-12 ID IDW20001761A patent/ID27511A/id unknown
- 1999-03-12 TR TR2000/02642T patent/TR200002642T2/xx unknown
- 1999-03-12 BR BR9908706-5A patent/BR9908706A/pt not_active IP Right Cessation
- 1999-03-12 KR KR1020007010037A patent/KR100595332B1/ko not_active IP Right Cessation
- 1999-03-12 CA CA002323456A patent/CA2323456A1/fr not_active Abandoned
- 1999-03-12 US US09/646,005 patent/US6589984B1/en not_active Expired - Fee Related
- 1999-03-12 NZ NZ506802A patent/NZ506802A/xx unknown
- 1999-03-12 PL PL99343419A patent/PL343419A1/xx not_active Application Discontinuation
- 1999-03-12 JP JP2000535641A patent/JP3922884B2/ja not_active Expired - Fee Related
- 1999-03-12 HU HU0101381A patent/HUP0101381A3/hu unknown
- 1999-03-12 EE EEP200000504A patent/EE200000504A/xx unknown
- 1999-12-03 UA UA2000105676A patent/UA58587C2/uk unknown
-
2000
- 2000-09-08 IS IS5617A patent/IS5617A/is unknown
- 2000-09-11 NO NO20004517A patent/NO20004517L/no unknown
- 2000-09-12 HR HR20000600A patent/HRP20000600A2/hr not_active Application Discontinuation
- 2000-09-12 BG BG104761A patent/BG104761A/xx unknown
-
2003
- 2003-05-12 US US10/435,746 patent/US20030186976A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0101381A3 (en) | 2002-06-28 |
| TR200002642T2 (tr) | 2001-01-22 |
| DE69917237T2 (de) | 2005-05-04 |
| NO20004517D0 (no) | 2000-09-11 |
| EE200000504A (et) | 2002-02-15 |
| CN1299359A (zh) | 2001-06-13 |
| KR100595332B1 (ko) | 2006-07-03 |
| HUP0101381A2 (hu) | 2002-05-29 |
| JP3922884B2 (ja) | 2007-05-30 |
| SK13412000A3 (sk) | 2001-04-09 |
| BR9908706A (pt) | 2000-11-21 |
| EP1063235A4 (fr) | 2003-01-07 |
| UA58587C2 (uk) | 2003-08-15 |
| ID27511A (id) | 2001-04-12 |
| AU756965B2 (en) | 2003-01-30 |
| EP1063235B1 (fr) | 2004-05-12 |
| IS5617A (is) | 2000-09-08 |
| PL343419A1 (en) | 2001-08-13 |
| ATE266659T1 (de) | 2004-05-15 |
| US20030186976A1 (en) | 2003-10-02 |
| WO1999046262A1 (fr) | 1999-09-16 |
| IL138279A0 (en) | 2001-10-31 |
| US6589984B1 (en) | 2003-07-08 |
| NO20004517L (no) | 2000-09-11 |
| DE69917237D1 (de) | 2004-06-17 |
| RU2199536C2 (ru) | 2003-02-27 |
| NZ506802A (en) | 2002-11-26 |
| CA2323456A1 (fr) | 1999-09-16 |
| EP1063235A1 (fr) | 2000-12-27 |
| KR20010041776A (ko) | 2001-05-25 |
| HRP20000600A2 (en) | 2001-06-30 |
| AU3277399A (en) | 1999-09-27 |
| CN1170827C (zh) | 2004-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG104761A (en) | Benzofurylpyrone derivatives | |
| AU5651680A (en) | Benzopyran derivatives | |
| PT1022274E (pt) | Intermediarios para a preparacao de derivados de oxazolidinodiona e de tiazolidinodiona | |
| DK0915866T3 (da) | Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre | |
| PT868182E (pt) | Processo para a producao de derivados de piperidina | |
| NO992259D0 (no) | Ny anvendelse for 1,3-propandiolderivater | |
| DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
| EA200000484A1 (ru) | Способ получения производных тиазолидиндиона | |
| PT90986A (pt) | Processo para a preparacao de esteres de estramustina e de composicoes farmaceuticas que os contem | |
| CA2046050A1 (fr) | Derives de bis[4-(2,6-di-alkyl)phenol]silane utilises comme agents antiatherosclereux | |
| ES2162042T3 (es) | Proceso para preparar derivados de galantamina por reduccion asimetrica. | |
| KR880012576A (ko) | 카르복시스티렌 유도체 및 이것을 유효성분으로 함유하는 약제 | |
| KR850004959A (ko) | 아릴옥시-n-(아미노알킬)-1-피롤리딘 및 피페리딘 카복스 아미드 및 카보티오 아미드의 제조방법 | |
| ATE148128T1 (de) | Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung | |
| DE69222076D1 (de) | Benzothiazolederivate | |
| IE892294L (en) | Cycloalkylthiazole derivatives | |
| AU2639999A (en) | Intermediate compounds in the synthesis of the a ring moiety of 2-substituted vitamin d derivatives | |
| DE69015220D1 (de) | Glycocyamidin-Derivate. | |
| DE69103985D1 (de) | N-Alkylthiazolidinderivate. | |
| AU4776399A (en) | Benflumetol derivatives, intermediates thereof and their use against parasiticalprotozoa and trematodes | |
| DE69314929D1 (de) | Benzolderivate | |
| ATE309212T1 (de) | Optisch aktive 1-phenylpyrrolidonderivate | |
| EP1466900A4 (fr) | Derives de la vitamine d-double substitution |